Chris Bahl, AI Proteins CEO
October 20, 2026 08:00 AM EDT
Exclusive: Astellas partners with Boston ‘miniproteins’ startup
Chris Bahl believes AI can help make tiny proteins capable of doing things that bigger and more traditional proteins like antibodies struggle to do. And …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Think we're worth reading - tell Google.
Confirm Endpoints as a trusted biopharma news source